Sangamo Therapeutics Inc (SGMO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

7000 MARINA BLVD BRISBANE, CA 94005

Sangamo Therapeutics, Inc. operates as a biotechnology company. The Company focuses on research and development of genomic therapies, as well as develops medicines for patient with genetic diseases. Sangamo Therapeutics serves customers in the United States.

Data as of 2021-05-08 10:21:43 -0400
Market Cap1.517 Billion Shares Outstanding143.881 Million Avg 30-day Volume1.03 Million
P/E Ratio-12.22835 Dividend Yield EPS-0.878
Price/Sales11.54 Debt to Equity1.86 EBITDA-117.399 Million
Price to Book Value3.22 Forward PE-8.62 Enterprise Value929.427 Million
Total Cash587.084 Million Current Debt132.839 Million Gross Profit131.396 Million
BETA0.79619 52-week High/Low19.43 / 8.51 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SGMO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 218 206 5.83% 63 (3.78%) 61 (3.8%) 3.28%
13F shares: 78.241 Million 81.593 Million -4.11% 22.21 Million 25.088 Million -11.47%
% Ownership 55.3167 57.6867 -4.11% 15.7024 17.7377 -11.47%
New Positions: 38 32 18.75% 13 13 0.0%
Increased Positions 68 55 23.64% 19 22 -13.64%
Closed Positions 25 23 8.7% 11 8 37.5%
Reduced Positions 70 69 1.45% 22 18 22.22%
Total Calls 2.561 Million 1.436 Million 78.36% 416.3 Thousand 399.4 Thousand 4.23%
Total Puts 1.39 Million 1.122 Million 23.92% 407.4 Thousand 232.4 Thousand 75.3%
PUT/CALL Ratio 0.54 0.78 -30.77% 0.98 0.58 68.97%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SGMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SGMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

17.5 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

12 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DURAIBABU PRATHYUSHA VP, PFO AND PAO

  • Officer
40,128 2021-04-25 5

FONTENOT JASON D. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
62,496 2021-04-25 2

LOEB GARY EVP, GENERAL COUNSEL & SEC.

  • Officer
321,257 2021-03-23 2

RAMASASTRY SAIRA

  • Director
39,600 2021-02-25 4

PARKER H STEWART

  • Director
47,600 2021-02-25 3

MACRAE SANDY PRESIDENT AND CEO

  • Officer
  • Director
623,816 2021-02-25 2

CAREY ROBERT

  • Director
39,600 2021-02-25 3

ZAKRZEWSKI JOSEPH S

  • Director
64,600 2021-02-25 3

SMITH KAREN L.

  • Director
42,100 2021-02-25 3

RAMELMEIER ROLF ANDREW EVP, TECHNICAL OPERATIONS

  • Officer
178,199 2021-02-25 3

MEYERS JAMES R

  • Director
39,600 2021-02-25 3

MARKELS JOHN

  • Director
29,600 2021-02-25 1

MCCLUNG DAVID MARK EVP, CHIEF BUSINESS OFFICER

  • Officer
220,000 2021-02-25 2

HILLAN KENNETH J.

  • Director
39,600 2021-02-25 3

SCHOTT ROBERT J. SVP, HEAD OF DEVELOPMENT

  • Officer
40,000 2021-02-12 2

LEE SUNG EVP, CHIEF FINANCIAL OFFICER

  • Officer
88,708 2020-11-25 1

BOISSEL STEPHANE EVP, CORP. STRATEGY

  • Officer
70,116 2020-06-04 1

DILLY STEPHEN GEORGE

  • Director
15,000 2020-05-18 2

BIOGEN INC.

BIOGEN MA INC.

  • 10% Owner
24,420,157 2020-04-08 0

WOOLFSON ADRIAN EVP RESEARCH & DEVELOPMENT

  • Officer
50,000 2020-02-25 0

YI KATHY EVP & CHIEF FINANCIAL OFFICER

  • Officer
25,512 2019-05-15 0

TURNER HEATHER D EVP, GENERAL COUNSEL & SEC.

  • Officer
19,250 2019-02-25 0

CONNER EDWARD R. SR. VP & CHIEF MEDICAL OFFICER

  • Officer
11,291 2019-01-24 0

JEFFS ROGER

  • Director
9,908 2018-09-07 0

MENTO STEVEN J

  • Director
46,546 2018-06-11 0

HERBERTS CURT A. III SR.VP & CHIEF BUSINESS OFFICER

  • Officer
14,625 2018-04-13 0

RINGO WILLIAM R

  • Director
800 2017-09-20 0

LANPHIER EDWARD O II

  • Director
1,293,782 2016-12-31 0

WOLFF HENRY WARD EXEC VP & CFO

  • Officer
206,829 2016-12-12 0

CLEVELAND PAUL B

  • Director
0 2016-06-14 0

NICHOL GEOFFREY EXECUTIVE VICE PRESIDENT, R&D

  • Officer
159,676 2015-12-11 0

ANDO DALE G VP, THERAPEUTIC DEV. & CMO

  • Officer
107,328 2015-12-11 0

LARSON JOHN WILLIAM

  • Director
0 2015-06-22 0

GREGORY PHILIP D SVP OF RESEARCH & CSO

  • Officer
116,410 2015-06-01 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • 10% Owner
3,683,002 2014-01-29 0

ICHIKAWA DAVID G SENIOR VP, BUS. DEV.

  • Officer
25,000 2011-12-08 0

WIGGANS THOMAS G

  • Director
0 2011-06-01 0

GERBER WILLIAM G

  • Director
0 2010-06-02 0

LIU MARGARET

  • Director
0 2008-06-04 0

WOOD MICHAEL C

  • Director
0 2008-06-04 0

ZANTE GREG VP, FINANCE & ADMINISTRATION

  • Officer
No longer subject to file 2008-03-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FONTENOT JASON D. - Officer SVP, CHIEF SCIENTIFIC OFFICER

2021-04-27 20:49:57 -0400 2021-04-25 F 811 $11.71 d 62,496 direct -3.4874 -15.734 0.0 1 -15.734 6

DURAIBABU PRATHYUSHA - Officer VP, PFO AND PAO

2021-04-27 20:49:01 -0400 2021-04-25 F 662 $11.71 d 40,128 direct -3.4874 -15.734 0.0 1 -15.734 6

DURAIBABU PRATHYUSHA - Officer VP, PFO AND PAO

2021-03-29 19:11:35 -0400 2021-03-25 F 345 $12.27 d 40,790 direct 7.3693 -3.6847 -10.2828 8.3119 4 -12.8535 29

DURAIBABU PRATHYUSHA - Officer VP, PFO AND PAO

2021-04-27 20:46:52 -0400 2021-03-25 F 345 $12.27 d 40,790 direct -3.4874 -15.734 0.0 1 -15.734 6

LOEB GARY - Officer EVP, GENERAL COUNSEL & SEC.

2021-03-25 19:19:47 -0400 2021-03-23 M 11,981 $11.02 a 100,762 direct -3.4167 5.3333 -15.25 5.3333 6 -15.25 31

LOEB GARY - Officer EVP, GENERAL COUNSEL & SEC.

2021-03-25 19:19:47 -0400 2021-03-23 S 5,000 $13.18 d 83,781 direct -3.4167 5.3333 -15.25 5.3333 6 -15.25 31

LOEB GARY - Officer EVP, GENERAL COUNSEL & SEC.

2021-03-25 19:19:47 -0400 2021-03-23 M 11,981 d 238,019 direct

LOEB GARY - Officer EVP, GENERAL COUNSEL & SEC.

2021-03-25 19:19:47 -0400 2021-03-23 S 11,981 $13.10 d 88,781 direct -3.4167 5.3333 -15.25 5.3333 6 -15.25 31

LOEB GARY - Officer EVP, GENERAL COUNSEL & SEC.

2021-03-25 19:19:47 -0400 2021-03-23 S 543 $13.17 d 83,238 direct -3.4167 5.3333 -15.25 5.3333 6 -15.25 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 22:15:03 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 21:45:03 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 21:15:03 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 20:45:03 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 20:15:04 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 19:45:02 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 19:15:03 UTC -0.205 0.255 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 18:45:03 UTC -0.2 0.25 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 18:15:03 UTC -0.2 0.25 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 17:45:03 UTC -0.2 0.25 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 17:15:03 UTC -0.2 0.25 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 16:45:03 UTC -0.2179 0.2679 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 16:15:03 UTC -0.2179 0.2679 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 15:45:03 UTC -0.2179 0.2679 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 15:15:02 UTC -0.2179 0.2679 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 14:45:04 UTC -0.2102 0.2602 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 14:15:03 UTC -0.2102 0.2602 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 13:45:03 UTC -0.2102 0.2602 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 13:15:03 UTC -0.2102 0.2602 3000000
SANGAMO THERAPEUTICS INC SGMO 2021-05-14 12:45:03 UTC -0.2102 0.2602 3000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund SGMO -521.0 shares, $-8130.21 2020-12-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund SGMO -402.0 shares, $-2560.74 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund SGMO -8401.0 shares, $-131097.61 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund SGMO -488.0 shares, $-3108.56 2020-03-31 N-PORT

Elevate your investments